Hillsdale Investment Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Hillsdale Investment Management's HALO Position: Q2 2026 in Review
Hillsdale Investment Management reduced its Halozyme (HALO) stake by 81% in Q2 2026, selling an estimated $6.1M and leaving 20,530 shares worth $1.61M. The position accounts for 0.04% of the portfolio, ranked #328.
Hillsdale Investment Management first reported a position in HALO in Q3 2019 and has held it in 14 quarters since. The position peaked at $7.23M in Q4 2025. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Hillsdale Investment Management held 20,530 shares of Halozyme worth $1.61M as of Q2 2026.
- Hillsdale Investment Management sold 89,520 Halozyme shares in Q2 2026, an estimated $6.1M.
- Halozyme made up 0.04% of Hillsdale Investment Management's portfolio in Q2 2026, its #328 holding.
- Hillsdale Investment Management first reported a position in Halozyme in Q3 2019 and has held it in 14 quarters since.
- Hillsdale Investment Management's Halozyme position peaked at $7.23M in Q4 2025.
- 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.